Bortezomib Sandoz 1 mg
Bortezomib Sandoz 1 mg is a medicine authorised by Swissmedic under authorisation number 67167. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 13 November 2018 and the authorisation is valid without a time limit. ATC code L01XG01 places the medicine in the group Antineoplastic agents.
| Authorisation number | 67167 |
|---|---|
| Name | Bortezomib Sandoz 1 mg |
| Full name | Bortezomib Sandoz 1 mg, Pulver zur Herstellung einer Injektionslösung |
| Authorisation holder | Sandoz Pharmaceuticals AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01XG01 |
| First authorisation | 13 November 2018 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Bortezomib Sandoz 1 mg, Pulver zur Herstellung einer Injektionslösung | A | 13 November 2018 |
| 2 | Bortezomib Sandoz 3.5 mg, Pulver zur Herstellung einer Injektionslösung | A | 13 November 2018 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | L01XG01 | 07.16.1. | A |
| 2 | 1 | Durchstechflasche(n) | L01XG01 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Bortezomib Sandoz 1 mg authorised in Switzerland?
Yes. Bortezomib Sandoz 1 mg is authorised by Swissmedic under authorisation number 67167, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Bortezomib Sandoz 1 mg have?
Bortezomib Sandoz 1 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Bortezomib Sandoz 1 mg?
The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.